Abstract :
[en] Zoonosis of chimpanzee simian immunodeficiency virus cpz to humans has given rise to both
pandemic (M) and non-pandemic (O, N and P) groups of human immunodeficiency virus type-1
(HIV). These lentiviruses encode accessory proteins, including Vpu, which has been shown to
reduce CD4 levels on the cell surface, as well as increase virion release from the cell by
antagonizing tetherin (CD317, BST2). Here, we confirm that O group Vpus (Ca9 and BCF06) are
unable to counteract tetherin or downregulate the protein from the cell surface, although they are still able to reduce cell-surface CD4 levels. We hypothesize that this inability to antagonize
tetherin may have contributed to O group viruses failing to achieve pandemic levels of human-tohuman transmission. Characterization of chimeric O/M group Vpus and Vpu mutants demonstrate that the Vpu–tetherin interaction is complex, involving several domains. We identify specific residues within the transmembrane proximal region that, along with the transmembrane domain, are crucial for tetherin counteraction and enhanced virion release. We have also shown that the critical domains are responsible for the localization of M group Vpu to the trans-Golgi network, where it relocalizes tetherin to counteract its function. This work sheds light on the acquisition of anti-tetherin activity and the molecular details of pandemic HIV infection in humans
Scopus citations®
without self-citations
13